Circulating Biomarkers Market 2027 By Product, End User | The Insight Partners

Circulating Biomarkers Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Circulating DNA, Circulating Tumor Cells, Other); End User (Hospitals, Medical Research Center, Others)

Report Code: TIPRE00015763 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Biomarkers provides a powerful way to understand chronic neurological diseases with respect to applications in epidemiology, clinical trials, and other screening aspects. Circulating biomarkers majorly includes extracellular vesicles, nucleic acids, and proteins from metastatic sites.

MARKET DYNAMICS

The circulating biomarkers market is expected to witness considerable growth due to increasing adoption of biomarkers for diagnostic purpose and rising prevalence of cancer. However, high capital investment required for circulating biomarkers is likely to hamper the growth of the global circulating biomarkers market.

MARKET SCOPE

The "Circulating Biomarkers Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Circulating Biomarkers Market with detailed market segmentation by product and end user. The Circulating Biomarkers Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Circulating Biomarkers Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The circulating biomarkers market is segmented on the basis of product and end user. Based on product, the market is segmented as circulating DNA, circulating tumor cells, and other. On the basis of end user, the market is segmented as hospitals, medical research center, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Circulating Biomarkers Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Circulating Biomarkers Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Circulating Biomarkers Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Circulating Biomarkers market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Circulating Biomarkers Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Circulating Biomarkers Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Circulating Biomarkers Market.

The report also includes the profiles of key players in Circulating Biomarkers Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GE Healthcare
  •  Agilent Technologies
  •  Epigenomics AG
  •  Fluxion Biosciences
  •  Affymetrix
  •  BD
  •  Abbott Laboratories
  •  Biocept

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Circulating Biomarkers Market - By Product
1.3.2 Circulating Biomarkers Market - By End User
1.3.3 Circulating Biomarkers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CIRCULATING BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CIRCULATING BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CIRCULATING BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. CIRCULATING BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. CIRCULATING BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CIRCULATING BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CIRCULATING DNA
7.3.1. Overview
7.3.2. Circulating DNA Market Forecast and Analysis
7.4. CIRCULATING TUMOR CELLS
7.4.1. Overview
7.4.2. Circulating Tumor Cells Market Forecast and Analysis
7.5. OTHER
7.5.1. Overview
7.5.2. Other Market Forecast and Analysis
8. CIRCULATING BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. MEDICAL RESEARCH CENTER
8.4.1. Overview
8.4.2. Medical Research Center Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CIRCULATING BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Circulating Biomarkers Market Overview
9.1.2 North America Circulating Biomarkers Market Forecasts and Analysis
9.1.3 North America Circulating Biomarkers Market Forecasts and Analysis - By Product
9.1.4 North America Circulating Biomarkers Market Forecasts and Analysis - By End User
9.1.5 North America Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Circulating Biomarkers Market
9.1.5.1.1 United States Circulating Biomarkers Market by Product
9.1.5.1.2 United States Circulating Biomarkers Market by End User
9.1.5.2 Canada Circulating Biomarkers Market
9.1.5.2.1 Canada Circulating Biomarkers Market by Product
9.1.5.2.2 Canada Circulating Biomarkers Market by End User
9.1.5.3 Mexico Circulating Biomarkers Market
9.1.5.3.1 Mexico Circulating Biomarkers Market by Product
9.1.5.3.2 Mexico Circulating Biomarkers Market by End User
9.2. EUROPE
9.2.1 Europe Circulating Biomarkers Market Overview
9.2.2 Europe Circulating Biomarkers Market Forecasts and Analysis
9.2.3 Europe Circulating Biomarkers Market Forecasts and Analysis - By Product
9.2.4 Europe Circulating Biomarkers Market Forecasts and Analysis - By End User
9.2.5 Europe Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Circulating Biomarkers Market
9.2.5.1.1 Germany Circulating Biomarkers Market by Product
9.2.5.1.2 Germany Circulating Biomarkers Market by End User
9.2.5.2 France Circulating Biomarkers Market
9.2.5.2.1 France Circulating Biomarkers Market by Product
9.2.5.2.2 France Circulating Biomarkers Market by End User
9.2.5.3 Italy Circulating Biomarkers Market
9.2.5.3.1 Italy Circulating Biomarkers Market by Product
9.2.5.3.2 Italy Circulating Biomarkers Market by End User
9.2.5.4 Spain Circulating Biomarkers Market
9.2.5.4.1 Spain Circulating Biomarkers Market by Product
9.2.5.4.2 Spain Circulating Biomarkers Market by End User
9.2.5.5 United Kingdom Circulating Biomarkers Market
9.2.5.5.1 United Kingdom Circulating Biomarkers Market by Product
9.2.5.5.2 United Kingdom Circulating Biomarkers Market by End User
9.2.5.6 Rest of Europe Circulating Biomarkers Market
9.2.5.6.1 Rest of Europe Circulating Biomarkers Market by Product
9.2.5.6.2 Rest of Europe Circulating Biomarkers Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Circulating Biomarkers Market Overview
9.3.2 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis
9.3.3 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Circulating Biomarkers Market
9.3.5.1.1 Australia Circulating Biomarkers Market by Product
9.3.5.1.2 Australia Circulating Biomarkers Market by End User
9.3.5.2 China Circulating Biomarkers Market
9.3.5.2.1 China Circulating Biomarkers Market by Product
9.3.5.2.2 China Circulating Biomarkers Market by End User
9.3.5.3 India Circulating Biomarkers Market
9.3.5.3.1 India Circulating Biomarkers Market by Product
9.3.5.3.2 India Circulating Biomarkers Market by End User
9.3.5.4 Japan Circulating Biomarkers Market
9.3.5.4.1 Japan Circulating Biomarkers Market by Product
9.3.5.4.2 Japan Circulating Biomarkers Market by End User
9.3.5.5 Rest of Asia-Pacific Circulating Biomarkers Market
9.3.5.5.1 Rest of Asia-Pacific Circulating Biomarkers Market by Product
9.3.5.5.2 Rest of Asia-Pacific Circulating Biomarkers Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Circulating Biomarkers Market Overview
9.4.2 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis
9.4.3 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Circulating Biomarkers Market
9.4.5.1.1 South Africa Circulating Biomarkers Market by Product
9.4.5.1.2 South Africa Circulating Biomarkers Market by End User
9.4.5.2 Saudi Arabia Circulating Biomarkers Market
9.4.5.2.1 Saudi Arabia Circulating Biomarkers Market by Product
9.4.5.2.2 Saudi Arabia Circulating Biomarkers Market by End User
9.4.5.3 Rest of Middle East and Africa Circulating Biomarkers Market
9.4.5.3.1 Rest of Middle East and Africa Circulating Biomarkers Market by Product
9.4.5.3.2 Rest of Middle East and Africa Circulating Biomarkers Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Circulating Biomarkers Market Overview
9.5.2 South and Central America Circulating Biomarkers Market Forecasts and Analysis
9.5.3 South and Central America Circulating Biomarkers Market Forecasts and Analysis - By Product
9.5.4 South and Central America Circulating Biomarkers Market Forecasts and Analysis - By End User
9.5.5 South and Central America Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Circulating Biomarkers Market
9.5.5.1.1 Brazil Circulating Biomarkers Market by Product
9.5.5.1.2 Brazil Circulating Biomarkers Market by End User
9.5.5.2 Argentina Circulating Biomarkers Market
9.5.5.2.1 Argentina Circulating Biomarkers Market by Product
9.5.5.2.2 Argentina Circulating Biomarkers Market by End User
9.5.5.3 Rest of South and Central America Circulating Biomarkers Market
9.5.5.3.1 Rest of South and Central America Circulating Biomarkers Market by Product
9.5.5.3.2 Rest of South and Central America Circulating Biomarkers Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CIRCULATING BIOMARKERS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CIRCULATING BIOMARKERS MARKET, KEY COMPANY PROFILES
12.1. GE HEALTHCARE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AGILENT TECHNOLOGIES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EPIGENOMICS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. FLUXION BIOSCIENCES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AFFYMETRIX
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ABBOTT LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOCEPT
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. GE Healthcare
2. Agilent Technologies
3. Epigenomics AG
4. Fluxion Biosciences
5. Affymetrix
6. BD
7. Abbott Laboratories
8. Biocept
TIPRE00015763
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking